Integrated Clinical and Biochemical Biomarker Approaches for Early Diagnosis of Cardiovascular Diseases

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for a significant burden on healthcare systems, particularly in developing countries. Early diagnosis is critical in reducing morbidity and mortality associated with heart diseases. This research paper explores the integration of clinical evaluation methods with biochemical biomarkers to enhance early detection of cardiovascular diseases. Traditional diagnostic approaches such as patient history, physical examination, electrocardiography (ECG), and imaging techniques are essential but often insufficient for detecting early-stage disease. The incorporation of biochemical markers such as cardiac troponins, creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), and high-sensitivity C-reactive protein (hs-CRP) has significantly improved diagnostic accuracy. This study adopts a descriptive and analytical approach using secondary data from peer-reviewed journals and clinical studies. It evaluates the effectiveness of combined diagnostic strategies in identifying early myocardial injury, inflammation, and cardiac dysfunction. The findings suggest that integrated approaches offer higher sensitivity and specificity compared to standalone diagnostic methods. Additionally, emerging biomarkers and advancements in laboratory technologies further enhance early detection capabilities. The paper concludes that a multidisciplinary diagnostic framework combining clinical assessment and biochemical analysis is essential for timely and accurate diagnosis of cardiovascular diseases. Such integration not only improves patient outcomes but also supports personalized treatment strategies. Future research should focus on developing cost-effective and accessible diagnostic tools for widespread implementation, particularly in resource-limited settings.